drugset / Trial / NCT00439179

A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema

NCT00439179

Phase 1 Completed 27 enrolled Brown University GlaxoSmithKline · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

A Phase I Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema

Timeline

Start
2006-07
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lapatinib Small molecule 1000 mg
Subject Lapatinib Small molecule 1500 mg
Subject Oxaliplatin Small molecule
Background Gemcitabine Small molecule